http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0550719-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b05d5871638d5180bb954591361c7635 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate | 1992-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4f64b8d01d397b622a4314133e8775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e8a7c2fbc193a16b3c9f8811280f033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcf0ffe7428cc42327456bc3d73b060 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5afec992d5c269610da4694ce5cd93c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed230d93f47c6e39dd1cfc4f13a08005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8bfcf78c3f99fa18cc71f005bc3d2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e0c399a2688bde93c1bc154828ad3a3 |
| publicationDate | 1993-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0550719-A1 |
| titleOfInvention | NERVOUS PLANTING SYSTEM. |
| abstract | Implantable therapeutic systems for local and regulated delivery of a biologically active factor to the brain, spinal cord and other target regions of a subject suffering from a debilitating infection. The method involves surgically exposing an insertion site, generally located above a predetermined treatment site (12), in a patient. A cannula (20), in which an obturator (30) is placed, is inserted at the insertion site, thereby providing a path to the treatment site. The cannula (20) is preferably made of a low friction polymeric material, such as polytetrafluoroethylene. The cannula (20) generally has an open proximal end for receiving the obturator (30), and an open distal end for delivering neurologically active factors to the treatment site (12). The obturator (30) is then withdrawn from the cannula (20), a biocompatible vehicle (40) retained by a clip (40) and containing a biologically active material is inserted into the cannula along the path. A guide wire (30) can be inserted into the cannula behind the vehicle (40) to place the proximal end of the vehicle at the proximal end of the cannula (20b). Once the vehicle (40) is placed near the proximal end of the cannula (20), the cannula is removed first, then the guidewire (32), leaving the vehicle (40) in place. at the treatment site (12). |
| priorityDate | 1991-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 350.